Abstract
Pancreatic adenocarcinoma is a highly lethal disease with a high morbidity and dismal prognosis. A multidisciplinary consultation based on evidence-based medicine has become the main modality for treatment of pancreatic adenocarcinoma. National Comprehensive Cancer Network (NCCN) clinical practice guidelines in oncology has been widely recognized and implemented. Recently, the guidelines (version 1. 2017) in oncology have been published by NCCN. This article will summarize and interpret the updates of the new version of the NCCN guideline for pancreatic adenocarcinoma. Key words: Pancreatic neoplasms; Diagnosis; Therapy; Guideline; Understanding
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
